This review summarizes the pathological mechanisms and therapeutic strategies for erectile dysfunction, encompassing lifestyle, pharmacological, physical, stem cell, and surgical approaches.
#IJDDP #ED #pathophysiology #therap
www.sciltp.com/journals/ijd...

Congratulations to Dr Edmond Kwan who was a finalist in the 2024-2025 Victorian Premier’s Awards for Health & Medical Research - Clinical Researcher Award category for his ctDNA research work into the @anzuptrials.bsky.social #TheraP trial anzup.org.au/news/anzups-... @profiand.bsky.social

In an ever-stressful world, finding support can be tough. 🌎💔 #ai #Therap... youtube.com/shorts/f5dMT... via @YouTube

Congrats @anzuptrials.bsky.social #TheraP study presented #ASCO25 by #AslıMunzur #PCF #BCCancerFoundation @terryfoxfoundation.bsky.social‬ #CanadianCancerSociety @petermaccc.bsky.social‬ #VancouverPC #VCHResearchInstitute #UBC #PCFA #Movember @ansto.bsky.social‬ #NHMRCCTC #GentlemansRide #Novartis

Thread by @EdmondMKwan on Thread Reader App @EdmondMKwan: On the eve of #ASCO25, I am delighted to share results from the correlative analyses of the @ANZUPtrials phase II TheraP study, now published in @NatureMedicine. Massive effort supported...

Amazing work by Ed Kwan and team, well done!
@anzuptrials.bsky.social @monashuniversity.bsky.social @easternhealthau.bsky.social @drmhofman.bsky.social @pcf-science.bsky.social #MonashBDI #EHCSMonash #AlexWyatt #ArunAzad #VanProstateCtr #PCFA #ASCO25 #TheraP #ProstateCancer #pcsm #GUOncology

Online Therapy for Agoraphobia Online Mindfulness Therapy for Agoraphobia via Skype. Learn how to overcome agoraphobia through Mindfulness-based Exposure Therapy.

See an Online Psychotherapist for the treatment of #Agoraphobia via Skype.
Online Mindfulness-based Exposure Therapy for overcoming agoraphobia.
See: https://buff.ly/3TZZiDQ
#agoraphobiarecovery #agoraphobiatreatment #anxiety #mentalhealth #counseling #therap…

Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prost... These results support the use of [177Lu]Lu-PSMA-617 as an alternative to cabazitaxel for PSMA-positive metastatic castration-resistant prostate cancer progressing after docetaxel. We did not find evid...

Great to see the @anzuptrials.bsky.social #TheraP #ClinicalTrial overall survival data published today in Lancet Oncology: #LuPSMA vs #cabazitaxel in #ProstateCancer

www.thelancet.com/journals/lan...